Storage and handling
Other information store at room temperature
Vaniply Ointment, Improved Formula
- Manufacturer
- Pharmaceutical Specialties, Inc.
- Effective date
- 2019-10-07
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:08:26
Label at a glance#
ProductVaniply
Active ingredientDIMETHICONE
Label structure15 sections
Contacts and useful links#
Websitewww.vanicream.com
www.vanicream.com
www.vanicream.comLabel contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
Active ingredient
Dimethicone, 2%
OTC - PURPOSE SECTION
Purpose
Skin Protectant
INDICATIONS & USAGE SECTION
Uses
- helps prevent and temporarily protects and helps relieve chafed, chapped or cracked skin and lips
- helps prevent and protect from the drying effects of wind and cold weather
WARNINGS SECTION
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on
- deep or puncture wounds
- animal bites
- serious burns
OTC - WHEN USING SECTION
When using this product
- do not get into eyes
OTC - STOP USE SECTION
Stop use and ask a doctor if
- condition worsens
- symptoms last more than 7 days or clear up and occur again within a few days
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away
DOSAGE & ADMINISTRATION SECTION
Directions
- apply as needed
STORAGE AND HANDLING SECTION
Other information
- store at room temperature
INACTIVE INGREDIENT SECTION
Inactive ingredients C30-45 alkyl methicone, C30-45 olefin, hydrogenated polydecene, microcrystalline wax, polyethylene, silica dimethyl silylate
OTC - QUESTIONS SECTION
Questions?
1-800-325-8232 www.vanicream.com
SPL UNCLASSIFIED SECTION
Vaniply™ Ointment is a unique formulation that is easy-to-spread, non-greasy, and long-lasting. It protects and helps moisturize the skin.
Vanicream™ and Vaniply™ are trademarks or registered trademarks, of Pharmaceutical Specialties, Inc. in the US or other countries. © PSI 2010. All rights reserved.
PHARMACEUTICAL SPECIALTIES, INC.
ROCHESTER, MN 55901
Made in USA
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC 45334-601-01
DERMATOLOGIST TESTED
From the makers of VANICREAM™ Skin Cream
Improved Formula
VANIPLY™ Ointment for Sensitive Skin
Skin Protectant/Dry Skin Care
Free of dyes, fragrance, masking fragrance, lanolin, parabens, formaldehyde & other preservatives
Non-comedogenic • Gluten-free
Net Wt 13 oz (368 g)
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 45334-601-02 | GM - Gram | 45334-601 | d1246331-fae9-498e-b089-98b13f37a453 | 1 | 2018-04-19 |
Products#
Every source-derived product name is available through these pages.
- Vaniply
- Dimethicone
- SILICA DIMETHYL SILYLATE
- C30-45 OLEFIN
- HYDROGENATED POLYDECENE (550 MW)
- MICROCRYSTALLINE WAX
- HIGH DENSITY POLYETHYLENE
- C30-45 ALKYL METHICONE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 45334-601 | 45334-601-02, 45334-601-01, 45334-601-14, 45334-601-32 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SILICA DIMETHYL SILYLATE | EU2PSP0G0W | IACT |
| C30-45 OLEFIN | 6DWD51M0O8 | IACT |
| HYDROGENATED POLYDECENE (550 MW) | U333RI6EB7 | IACT |
| MICROCRYSTALLINE WAX | XOF597Q3KY | IACT |
| HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | IACT |
| C30-45 ALKYL METHICONE | NFX970DSI2 | IACT |
| DIMETHICONE | 92RU3N3Y1O | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 94530b47-31d8-688c-e053-2a95a90ab129 | 522db1e5-081e-70aa-e054-00144ff8d46c | 2019-10-07 | Warnings | 94530b47-31d8-688c-e053-2a95a90ab129 522db1e5-081e-70aa-e054-00144ff8d46c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.